LobbyingTersera Therapeutics lobbying by quarter
Tersera Therapeutics's latest lobbying report covers Q2 2026, at $80K. The four quarters Q4 2025–Q3 2026 total $220K. Its first report covers Q3 2025; the issues it reports most are Medicare/Medicaid.
Tersera Therapeutics
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $220K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2025 | $70K | 1 |
| Q4 2025 | $70K | 1 |
| Q1 2026 | $70K | 1 |
| Q2 2026 | $80K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$290K · 4 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Centers For Medicare and Medicaid Services (CMS)4 reports
- HOUSE OF REPRESENTATIVES4 reports
- SENATE4 reports
Firms it paid
| Firm | ||
|---|---|---|
| Tarplin, Downs & Young | $290K | 4 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JENNIFER B YOUNG | Asst. Sec. for Leg.- HHS; Dep. Asst. Sec for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff. Sen. Cmte. on Finance | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Tarplin, Downs & Young | $80K |
| 04/20for Q1 | Tarplin, Downs & Young | $70K |
| 01/20for Q4 2025 | Tarplin, Downs & Young | $70K |
| 25/10/20for Q3 2025 | Tarplin, Downs & Young | $70K |
| 25/09/22for Q3 2025 | Tarplin, Downs & Young | Under $5,000 |